September 17, 2008 9:00am EDT
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (AMEX:OPK) today announced that senior
management will present at the UBS 2008 Global Life Sciences
Conference on Tuesday, September 23, 2008 at 1:00 PM EDT. The
conference will be held at the Grand Hyatt New York in New York City.
OPKO senior management will provide a review of recent corporate
developments.
The audio portion of the company's presentation will be webcast
live. To access the audio webcast go to the OPKO Health, Inc. website
at www.opko.com and click on the icon for the presentation. An
archived version of the webcast will be available for 30 days
beginning three hours after the start of the presentation.
About OPKO Health, Inc.
Miami-based OPKO is a specialty healthcare company. Its lead
investigational drug, the gene silencing agent bevasiranib, is in
Phase III trials after successfully completing Phase II trials for wet
age-related macular degeneration and diabetic macular edema. OPKO is
developing a pipeline of novel agents for ophthalmic diseases, and it
markets innovative diagnostic imaging systems that complement the
company's therapeutic products. For more information visit the
company's website at www.opko.com .
Source: OPKO Health, Inc.
Released September 17, 2008
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page